Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Treatment outcomes in classic Hodgkin lymphoma: 5-year update from the Brazilian Hodgkin Lymphoma Registry.EJHaem · 2023
   Article
2. Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma.Blood · 2023
   Article
3. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.British journal of cancer · 2018
   Article
4. Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment.Seminars in oncology · 2017
   Article
5. Radiation Therapy for Advanced-Stage Hodgkin Lymphoma.Advances in radiation oncology
   Review

Corrections and comments

• Comment on
  Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.2016
• Comment on
  Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.2016

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as